期刊文献+

C-erbB-2、ER、PR在乳腺浸润性导管癌中的表达及意义 被引量:1

Expression levels and significance of C-erbB-2,ER and PR in patients with invasive breast ductal carcinoma
原文传递
导出
摘要 目的:探讨乳腺浸润性导管癌中ER、PR和C-erbB-2的表达,并分析其相关性。方法:应用免疫组化方法,检测60例乳腺浸润性导管癌患者中ER、PR和C-erbB-2的表达情况。结果:ER、PR和C-erbB-2的阳性表达率分别为58.3%(35/60)、41.7%(25/60)和40.0%(24/60);ER与PR表达之间差异有统计学意义(P<0.05);ER与C-erbB-2表达之间差异无统计学意义(P>0.05);PR与C-erbB-2表达之间差异无统计学意义(P>0.05)。结论:C-erbB-2和ER、PR可能是乳腺癌预后指标的独立因子,但C-erbB-2表达与ER、PR关系有待研究。ER、PR在乳腺癌中的表达有相关性。 Objective:To explore the expression levels and correlation of estrogen receptor(ER),progestogen receptor(PR) and C-erbB-2 in patients with invasive breast ductal carcinoma.Methods:The expression levels of ER,PR and C-erbB-2 in 60 patients with invasive breast ductal carcinoma were detected by immunohistochemical method.Results:The positive expression rates of ER,PR and C-erbB-2 were 58.3 %(35/60),41.7 %(25/60) and 40.0%(24/60),respectively.There was significant difference between ER and PR(P0.05).There was no significant difference between ER and C-erbB-2(P0.05).There was no significant difference between PR and C-erbB-2(P0.05).Conclusion:C-erbB-2,ER and PR are possibly independent factors of prognosis of breast carcinoma,but the relationship between C-erbB-2 expression and ER,PR needs more researches,there is correlation between ER expression and PR expression in breast carcinoma.
出处 《中国妇幼保健》 CAS 北大核心 2010年第7期972-973,共2页 Maternal and Child Health Care of China
关键词 乳腺癌 C-ERBB-2 雌激素受体 孕激素受体 Breast carcinoma C-erbB-2 Estrogen receptor Progestogen receptor
  • 相关文献

参考文献5

二级参考文献11

共引文献38

同被引文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部